In 2014, nearly 15.1 million people chose to undergo elective cosmetic procedures. Cosmetic surgical procedures all involve risks, compromises, and complications. Regardless of a physician's efforts to limit complications, spontaneous wound opening or wound dehiscence remains one of the most common to occur. Cosmetic surgery, perhaps more than any other subspecialty of medicine, walks a precarious balance of tension in effort to reduce laxity and elevate ptotic tissues. Historically, dehiscence with wound exposure more than 6.0 hours after spontaneous wound opening is managed conservatively with proper cleansing and dressing changes, with or without empiric antibiotics. Our research sought to determine whether delayed primary closure of a cosmetic wound dehiscence is a safe and viable option to improve patient care and satisfaction. A retrospective case evaluation, patients survey, and statistical evaluation revealed improved satisfaction with delayed primary closure of dehiscent wounds.
Minimally invasive facial cosmetic surgery procedures have seen an increase in numbers over the past decade. The two most common procedures are Botulinum toxin type A injection and soft-tissue fillers. Although soft-tissue fillers have a high safety profile, these materials have been recently associated with serious and irreversible complications. This article reviews complications associated with facial soft-tissue fillers and their management. In addition, ways to prevent these unwanted complications are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.